SREBF1 and Disorder of lipid metabolism: Together, the above findings indicate that WVBF treatment can significantly reduce FFA-induced lipid metabolism disorder, oxidative stress, and the inflammatory response in LO2 cells by activating PPARα and inhibiting fat synthesis of the SREBP-1c/FASN/ACC pathway.